LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.480
-0.040 (-2.63%)
Nov 21, 2024, 4:00 PM EST - Market closed

LAVA Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Jan '20
Market Capitalization
394292142--
Market Cap Growth
-11.32%-54.86%-35.10%---
Enterprise Value
-41-5744--
Last Close Price
1.521.583.505.50--
PS Ratio
5.556.144.7526.50--
PB Ratio
0.930.811.071.20--
P/TBV Ratio
1.100.811.071.20--
P/FCF Ratio
--26.62---
P/OCF Ratio
--22.76---
EV/Sales Ratio
--0.200.81--
EV/FCF Ratio
--1.13---
Debt / Equity Ratio
0.140.120.060.040.540.30
Debt / FCF Ratio
--1.58---
Asset Turnover
0.070.060.140.070.26-
Quick Ratio
6.236.516.2011.912.365.31
Current Ratio
6.396.626.4012.142.485.35
Return on Equity (ROE)
-45.30%-61.18%-31.22%-67.24%-236.57%-
Return on Assets (ROA)
-15.99%-22.06%-15.41%-34.13%-62.63%-
Return on Capital (ROIC)
-28.65%-36.29%-20.28%-40.40%-94.97%-
Earnings Yield
-58.57%-101.05%-34.68%-29.88%--
FCF Yield
-65.61%-95.58%3.76%-20.75%--
Buyback Yield / Dilution
-3.10%-3.12%-31.21%-4850.36%10.81%-
Total Shareholder Return
-3.10%-3.12%-31.21%-4850.36%10.81%-
Source: S&P Capital IQ. Standard template. Financial Sources.